Waqqas ShamsProject Analyst, Life Sciences
Waqqas Shams supports the neuroscience portfolio at TIAP (previously MaRS Innovation) through evaluation of early-stage research by conducting scientific, technical and intellectual property due diligence, assessing market potential and identifying potential industry partners to support new start-up ventures.
Prior to joining TIAP, Waqqas completed his PhD at Concordia University investigating the effects of steroid hormones in conjunction with antipsychotics for a more effective treatment for schizophrenia, in an animal model of the disease. In addition to his doctoral work, Waqqas was a statistics instructor at Concordia University, teaching psychology students the basic fundamentals of statistics and its applications in research.
Waqqas received his B.Sc., Honours in psychology from University of Toronto, Mississauga, and his PhD in Neuroscience from Concordia University.